Latham & Watkins LLP Represents SoftBank Vision Fund 2 in Opentrons’ US$200 Million Series C Financing

A Bay Area-based team advises the lead investor in the financing of the company aiming to transform healthcare and life sciences with vertically integrated, low-cost solutions.

September 23, 2021

Opentrons Labworks Inc., the developer of integrated lab platforms that serve life science and healthcare customers, has announced SoftBank Vision Fund 2 has led the company's US$200 million Series C investment with participation by Khosla Ventures.

Latham & Watkins LLP represents SoftBank Vision Fund 2 in the financing with a corporate deal team led by Bay Area partners Saad Khanani and Ben Potter, with Bay Area associates Sally Wong and Adam Zuckerman.

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.